Aura Biosciences, Inc. (AURA) Misses Q1 EPS by 6c May 11, 2026 05:10PM
H.C. Wainwright Reiterates Buy Rating on Aura Biosciences (AURA) Mar 31, 2026 06:43AM
Evercore ISI Resumes Aura Biosciences (AURA) at Outperform, PT $13 Nov 25, 2025 04:30PM
Aura Biosciences, Inc. (AURA) Tops Q3 EPS by 6c Nov 13, 2025 07:04AM
Aura Biosciences, Inc. (AURA) Reports In-Line Q2 EPS Aug 13, 2025 07:05PM


May 28, 2025 06:45AM H.C. Wainwright Assumes Aura Biosciences (AURA) at Buy
May 23, 2025 04:09AM Citizens JMP Reiterates Market Outperform Rating on Aura Biosciences (AURA)
May 19, 2025 04:07AM Citizens JMP Reiterates Market Outperform Rating on Aura Biosciences (AURA)
May 15, 2025 05:18PM Aura Biosciences, Inc. (AURA) Misses Q1 EPS by 7c
May 15, 2025 09:34AM Aura Biosciences (AURA) Prices Share Offering at $4.90/sh
May 15, 2025 06:30AM Aura Biosciences (AURA) Announces Proposed Share and Warrant Offering
Apr 23, 2025 04:16AM Citizens JMP Reiterates Market Outperform Rating on Aura Biosciences (AURA)
Apr 2, 2025 07:03AM Aura Biosciences (AURA) Announces Appointment of Teresa Bitetti to Board of Directors
Mar 26, 2025 04:08AM Aura Biosciences (AURA) PT Lowered to $19 at Citizens JMP
Mar 25, 2025 06:48AM Aura Biosciences (AURA) PT Raised to $25 at H.C. Wainwright
Mar 24, 2025 07:00AM Aura Biosciences (AURA) Presents Positive Data from Phase 1 Trial of Bel-sar
Mar 4, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Aura Biosciences (AURA)
Mar 3, 2025 07:01AM Aura Biosciences (AURA) Announces Additional Data from Ongoing Phase 1 Trial
Nov 12, 2024 04:11PM Aura Biosciences, Inc. (AURA) Tops Q3 EPS by 2c
Oct 18, 2024 08:17AM TD Cowen Reiterates Buy Rating on Aura Biosciences (AURA)
Oct 18, 2024 07:09AM Aura Biosciences (AURA) PT Raised to $23 at Scotiabank
Oct 18, 2024 06:41AM Aura Biosciences (AURA) PT Raised to $22 at H.C. Wainwright
Oct 18, 2024 05:40AM Aura Biosciences (AURA) PT Raised to $24 at BTIG
Oct 17, 2024 04:06PM Aura Biosciences (AURA): Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Ph
Sep 13, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Aura Biosciences (AURA)
Sep 12, 2024 02:29PM TD Cowen Reiterates Buy Rating on Aura Biosciences (AURA)
Sep 12, 2024 06:30AM Aura Biosciences (AURA) Reports Positive Phase 2 End of Study Results Evaluating Bel-sar
Aug 8, 2024 07:02AM Aura Biosciences, Inc. (AURA) Tops Q2 EPS by 4c